EC 1.1.1.188 (prostaglandin-F synthase) inhibitor

Term ID

CHEBI:77425

Synonyms

(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 11-oxidoreductase inhibitor
(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 11-oxidoreductase inhibitors
EC 1.1.1.188 (prostaglandin-F synthase) inhibitors
EC 1.1.1.188 inhibitor
EC 1.1.1.188 inhibitors
NADPH-dependent prostaglandin D2 11-keto reductase inhibitor
NADPH-dependent prostaglandin D2 11-keto reductase inhibitors
PGD2 11-ketoreductase inhibitor
PGD2 11-ketoreductase inhibitors
PGF synthetase inhibitor
PGF synthetase inhibitors
PGF2alpha synthetase inhibitor
PGF2alpha synthetase inhibitors
prostaglandin 11-keto reductase inhibitor
prostaglandin 11-keto reductase inhibitors
prostaglandin 11-ketoreductase inhibitor
prostaglandin 11-ketoreductase inhibitors
prostaglandin D2-ketoreductase inhibitor
prostaglandin D2-ketoreductase inhibitors
prostaglandin F synthase inhibitor
prostaglandin F synthase inhibitors
prostaglandin F synthetase inhibitor
prostaglandin F synthetase inhibitors
prostaglandin-D2 11-reductase inhibitor
prostaglandin-D2 11-reductase inhibitors
reductase, 15-hydroxy-11-oxoprostaglandin inhibitor
reductase, 15-hydroxy-11-oxoprostaglandin inhibitors
synthetase, prostaglandin F2alpha inhibitor
synthetase, prostaglandin F2alpha inhibitors

(all 29)

Definition

An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of prostaglandin-F synthase (EC 1.1.1.188).

References

Wikipedia:Prostaglandin-F_synthase

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from EC 1.1.1.188 (prostaglandin-F synthase) inhibitor

Phenotype where environments contain EC 1.1.1.188 (prostaglandin-F synthase) inhibitor

Phenotype modified by environments containing EC 1.1.1.188 (prostaglandin-F synthase) inhibitor

Phenotype affecting EC 1.1.1.188 (prostaglandin-F synthase) inhibitor

Human Disease Model